Fig. 1
From: Development of a multivariable improvement measure for gout
Percentage of subjects treated with pegloticase q2w or placebo reaching GMIM criteria at 3 and 6 months in the RCTs. Number of evaluable subjects is shown for each group. The percentage of responders is shown above the bars. a Results for all GMIM criteria and b Results for all criteria except urate < 6.0 mg/dL. The statistical analysis of the data is shown in the supplementary material